Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Thunbergia laurifolia* leaf extract (TLL), derived from the Thai medicinal plant known as Rang Chuet, is a botanical extract traditionally used for the detoxification of poisons. Recent research has explored its potential therapeutic applications in treating cognitive dysfunction and depression-like behaviors. Preclinical studies in olfactory bulbectomized (OBX) mice have demonstrated that TLL can ameliorate non-spatial short-term memory deficits and exhibit antidepressant-like actions. Its mechanism of action is linked to the modulation of the cholinergic system, specifically by reversing the down-regulation of choline acetyltransferase (ChAT) and muscarinic M1 receptor expression in the hippocampus, which are often compromised in neurodegenerative conditions like Alzheimer's disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thunbergia laurifolia leaf extract.